Chandan Healthcare Ltd. Stock Analysis CHANDAN.NS

Chandan Healthcare Ltd. engages in the provision of pathology investigations and radiology testing services. The company is headquartered in Lucknow, Uttar Pradesh and currently employs 1,192 full-time employees. The company went IPO on 2025-02-17. The firm offers a range of pharmaceutical products including medical consumables such as tablets, capsules, syrups, ointments, and a variety of dosage forms, including liquids, solids, and semisolids. The company also provides essential items, such as injectables and inhalers to meet the diverse healthcare needs of its customers. Its services are designed to detect early symptoms of diseases and support disease prevention by monitoring various health indicators. Its laboratory has several departments, including clinical biochemistry; clinical pathology; histopathology, cytopathology and immune histochemistry; microbiology and serology; molecular pathology, and cytogenetics. The company receives routine and specialized testing requests and related samples for testing from its central reference laboratories, satellite laboratories and collection centers.